A new category of patients in the diagnostic process of cystic fibrosis

Cystic fibrosis is a congenital genetically determined disorder caused by pathogenic mutations in both alleles of the CFTR protein gene. Due to its common occurrence in the European population as well as severe and chronic course, all neonates in Poland have been screened for this disease since 20...

Full description

Bibliographic Details
Main Authors: Martyna Ciastkowska, Mariusz Ciastkowski, Bolesław Kalicki
Format: Article
Language:English
Published: Medical Communications Sp. z o.o. 2017-06-01
Series:Pediatria i Medycyna Rodzinna
Subjects:
Online Access:http://www.pimr.pl/index.php/issues/2017-vol-13-no-2/a-new-category-of-patients-in-the-diagnostic-process-of-cystic-fibrosis?aid=1063
_version_ 1819132809050062848
author Martyna Ciastkowska
Mariusz Ciastkowski
Bolesław Kalicki
author_facet Martyna Ciastkowska
Mariusz Ciastkowski
Bolesław Kalicki
author_sort Martyna Ciastkowska
collection DOAJ
description Cystic fibrosis is a congenital genetically determined disorder caused by pathogenic mutations in both alleles of the CFTR protein gene. Due to its common occurrence in the European population as well as severe and chronic course, all neonates in Poland have been screened for this disease since 2009. This enables early diagnosis and specialist care over patients. The introduction of newborn screening has also resulted in distinguishing a new category of patients with the following diagnosis: cystic fibrosis screen positive, inconclusive diagnosis or CFTR-related metabolic syndrome. This group includes children with positive newborn screen results who do not present clinical symptoms suggestive of cystic fibrosis and in whom a mutation of unknown clinical consequences is detected and/or borderline sweat test results arrive in the course of further diagnosis. The prognosis in these patients is uncertain since some of them may develop symptoms of cystic fibrosis or CFTR-related metabolic syndrome at some point in the future while other may remain fully healthy. Patients with an inconclusive diagnosis of cystic fibrosis require specialist care, which enables their further observation, diagnosis or possible verification of the diagnosis and implementation of proper treatment. This strategy gradually supplements the knowledge on mutations that have uncertain clinical consequences. It is also significant that the patient’s family understand possible consequences of a cystic fibrosis screen positive, inconclusive diagnosis (CFSPID).
first_indexed 2024-12-22T09:37:18Z
format Article
id doaj.art-fd5f888cd52746c8a14000938276d0dc
institution Directory Open Access Journal
issn 1734-1531
2451-0742
language English
last_indexed 2024-12-22T09:37:18Z
publishDate 2017-06-01
publisher Medical Communications Sp. z o.o.
record_format Article
series Pediatria i Medycyna Rodzinna
spelling doaj.art-fd5f888cd52746c8a14000938276d0dc2022-12-21T18:30:49ZengMedical Communications Sp. z o.o.Pediatria i Medycyna Rodzinna1734-15312451-07422017-06-0113216316910.15557/PiMR.2017.0015A new category of patients in the diagnostic process of cystic fibrosisMartyna Ciastkowska0Mariusz Ciastkowski1Bolesław Kalicki2Department of Paediatrics, Paediatric Nephrology and Allergology, Military Institute of Medicine, Warsaw, Poland. Head of the Department: Associate Professor Bolesław Kalicki, MD, PhDDepartment of Paediatrics, Paediatric Nephrology and Allergology, Military Institute of Medicine, Warsaw, Poland. Head of the Department: Associate Professor Bolesław Kalicki, MD, PhDDepartment of Paediatrics, Paediatric Nephrology and Allergology, Military Institute of Medicine, Warsaw, Poland. Head of the Department: Associate Professor Bolesław Kalicki, MD, PhDCystic fibrosis is a congenital genetically determined disorder caused by pathogenic mutations in both alleles of the CFTR protein gene. Due to its common occurrence in the European population as well as severe and chronic course, all neonates in Poland have been screened for this disease since 2009. This enables early diagnosis and specialist care over patients. The introduction of newborn screening has also resulted in distinguishing a new category of patients with the following diagnosis: cystic fibrosis screen positive, inconclusive diagnosis or CFTR-related metabolic syndrome. This group includes children with positive newborn screen results who do not present clinical symptoms suggestive of cystic fibrosis and in whom a mutation of unknown clinical consequences is detected and/or borderline sweat test results arrive in the course of further diagnosis. The prognosis in these patients is uncertain since some of them may develop symptoms of cystic fibrosis or CFTR-related metabolic syndrome at some point in the future while other may remain fully healthy. Patients with an inconclusive diagnosis of cystic fibrosis require specialist care, which enables their further observation, diagnosis or possible verification of the diagnosis and implementation of proper treatment. This strategy gradually supplements the knowledge on mutations that have uncertain clinical consequences. It is also significant that the patient’s family understand possible consequences of a cystic fibrosis screen positive, inconclusive diagnosis (CFSPID).http://www.pimr.pl/index.php/issues/2017-vol-13-no-2/a-new-category-of-patients-in-the-diagnostic-process-of-cystic-fibrosis?aid=1063cystic fibrosisCF NBSCFSPIDCRMS
spellingShingle Martyna Ciastkowska
Mariusz Ciastkowski
Bolesław Kalicki
A new category of patients in the diagnostic process of cystic fibrosis
Pediatria i Medycyna Rodzinna
cystic fibrosis
CF NBS
CFSPID
CRMS
title A new category of patients in the diagnostic process of cystic fibrosis
title_full A new category of patients in the diagnostic process of cystic fibrosis
title_fullStr A new category of patients in the diagnostic process of cystic fibrosis
title_full_unstemmed A new category of patients in the diagnostic process of cystic fibrosis
title_short A new category of patients in the diagnostic process of cystic fibrosis
title_sort new category of patients in the diagnostic process of cystic fibrosis
topic cystic fibrosis
CF NBS
CFSPID
CRMS
url http://www.pimr.pl/index.php/issues/2017-vol-13-no-2/a-new-category-of-patients-in-the-diagnostic-process-of-cystic-fibrosis?aid=1063
work_keys_str_mv AT martynaciastkowska anewcategoryofpatientsinthediagnosticprocessofcysticfibrosis
AT mariuszciastkowski anewcategoryofpatientsinthediagnosticprocessofcysticfibrosis
AT bolesławkalicki anewcategoryofpatientsinthediagnosticprocessofcysticfibrosis
AT martynaciastkowska newcategoryofpatientsinthediagnosticprocessofcysticfibrosis
AT mariuszciastkowski newcategoryofpatientsinthediagnosticprocessofcysticfibrosis
AT bolesławkalicki newcategoryofpatientsinthediagnosticprocessofcysticfibrosis